| # | Drug | Count |
|---|---|---|
| 0 | ENTECAVIR | 3 |
| 1 | ENTECAVIR ANHYDROUS | 3 |
| 2 | VELPATASVIR AND SOFOSBUVIR | 2 |
| 3 | ABEMACICLIB | 1 |
| 4 | ADALIMUMAB | 1 |
| 5 | AMLODIPINE BESYLATE | 1 |
| 6 | AMOXICILLIN | 1 |
| 7 | DIAZEPAM | 1 |
| 8 | DIAZEPAM ORAL | 1 |
| 9 | DIAZEPAM ORAL SOLUTION (CONCENTRATE) | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ENTECAVIR | 3 | 0.0003 |
| 1 | VELPATASVIR AND SOFOSBUVIR | 2 | 0.0002 |
| 2 | ABEMACICLIB | 1 | 0.0000 |
| 3 | AMOXICILLIN | 1 | 0.0000 |
| 4 | DIAZEPAM ORAL | 1 | 0.0000 |
| 5 | TOCILIZUMAB | 1 | 0.0000 |
| 6 | DIAZEPAM | 1 | 0.0000 |
| 7 | NAPROXEN SODIUM | 1 | 0.0000 |
| 8 | AMLODIPINE BESYLATE | 1 | 0.0000 |
| 9 | PREDNISOLONE ORAL SOLUTION | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0001 |
| 1 | Hepatitis C Virus NS5A Inhibitor [EPC] | 2 | 0.0000 |
| 2 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 2 | 0.0000 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 4 | Opioid Agonist [EPC] | 1 | 0.0000 |
| 5 | Vitamin D [EPC] | 1 | 0.0000 |
| 6 | Vitamin B12 [EPC] | 1 | 0.0000 |
| 7 | Vitamin C [EPC] | 1 | 0.0000 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Kinase Inhibitor [EPC] | 1 | 0.0000 |